Aegerion is dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.

Aegerion is dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.

Aegerion is dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.

Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.

 

  

2013 Annual Report

  • Symbol: AEGR
  • Last Price: 21.585
  • Change: 0.125
  • Volume: 428000
  • Quote Date: 11/26/2014 1:01:23 PM